Total Funding
36
38
Total FundingPost-IPO Equity raised
Growth Score
0 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
119730
Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.
Acquired by 
Immunome
Wayne Volkmuth: SVP Informatics and IT, Co-founder
Jonathan Woo: Senior Vice President, Finance & Strategy, Co-Founder
About the Company
Atreca is a biopharmaceutical that develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen. Its product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target-derived from an antibody identified using its discovery
platform.
Women Founded
